Stay updated on BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.

Latest updates to the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page
- Check4 days agoChange DetectedThe page's revision label changed from v3.6.0 to v3.6.2, indicating a patch-level update to the page. No study data or instructions are altered by this change.SummaryDifference0.0%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page now shows that recruitment has ended, adds guidance sections (How to Read a Study Record, Common Questions, How to Join a Study), and standardizes the Intervention/Treatment label while updating to Revision: v3.6.0.SummaryDifference0.4%

- Check25 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a small update to the page metadata or formatting. This update does not modify the study details or other substantive content.SummaryDifference0.0%

- Check47 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4, indicating a backend/template release. No study data or visible content on the page was altered.SummaryDifference0.0%

- Check68 days agoChange DetectedThe page now displays a newer ClinicalTrials.gov site revision/version identifier (“Revision: v3.5.3”) instead of the previous one (“v3.5.0”). This reflects a system/UI update rather than a change to the study details.SummaryDifference0.0%

- Check104 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

Stay in the know with updates to BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BTX 1204 Safety in Moderate Atopic Dermatitis Clinical Trial page.